Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Galderma Pharma prepares new agent for rosacea

Feb. 2, 2012

New treatment for rosacea designed by Galderma Pharma

Feb. 1, 2012

Health Canada accepts CIP-Isotretinoin submission for review

Jan. 31, 2012

Auxilium Pharmaceuticals doses first patients in Xiaflex study

Jan. 27, 2012

FDA approves gel for actinic keratosis

Jan. 26, 2012

Photocure completes enrollment in phase IIb trial of Visonac

Jan. 16, 2012

Biocon reports phase III data on immunotherapy for chronic plaque psoriasis

Jan. 12, 2012

Scientists at Gene Signal disclose new peptides for wound healing

Jan. 12, 2012

Leo Pharma in-licenses Virobay product

Jan. 11, 2012

Toray, Japan Tobacco and Torii terminate joint development of TRK-820

Dec. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...